Existing evidence suggests that Entinostat and AACOCF3 are inhibitors of histone deacetylases (HDAC) and cytosolic Phospholipase A2 (cPLA2) and have shown high efficacy in inhibiting tumor growth 29, 42, 43. The gene discussed is HDAC9; the disease is neoplasm.